Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

Kai Lin Yang, Yih Chen Chang, Hui Ling Ko, Mau Shin Chi, Hsin Ell Wang, Pei Sung Hsu, Chen Chun Lin, Diana Yu Wung Yeh, Shang Jyh Kao, Jiunn Song Jiang, Kwan Hwa Chi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

Original languageEnglish
Pages (from-to)550-557
Number of pages8
JournalClinical Lung Cancer
Volume17
Issue number6
DOIs
Publication statusPublished - Nov 1 2016
Externally publishedYes

Fingerprint

Chemoradiotherapy
Non-Small Cell Lung Carcinoma
Survival
Maintenance Chemotherapy

Keywords

  • Chemoradiotherapy
  • Marginally operable
  • Non–small cell lung cancer
  • Stage IIIA
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. / Yang, Kai Lin; Chang, Yih Chen; Ko, Hui Ling; Chi, Mau Shin; Wang, Hsin Ell; Hsu, Pei Sung; Lin, Chen Chun; Yeh, Diana Yu Wung; Kao, Shang Jyh; Jiang, Jiunn Song; Chi, Kwan Hwa.

In: Clinical Lung Cancer, Vol. 17, No. 6, 01.11.2016, p. 550-557.

Research output: Contribution to journalArticle

Yang, KL, Chang, YC, Ko, HL, Chi, MS, Wang, HE, Hsu, PS, Lin, CC, Yeh, DYW, Kao, SJ, Jiang, JS & Chi, KH 2016, 'Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery', Clinical Lung Cancer, vol. 17, no. 6, pp. 550-557. https://doi.org/10.1016/j.cllc.2016.05.013
Yang, Kai Lin ; Chang, Yih Chen ; Ko, Hui Ling ; Chi, Mau Shin ; Wang, Hsin Ell ; Hsu, Pei Sung ; Lin, Chen Chun ; Yeh, Diana Yu Wung ; Kao, Shang Jyh ; Jiang, Jiunn Song ; Chi, Kwan Hwa. / Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. In: Clinical Lung Cancer. 2016 ; Vol. 17, No. 6. pp. 550-557.
@article{f2211bcb06214440860d2e29137195f1,
title = "Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery",
abstract = "Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.",
keywords = "Chemoradiotherapy, Marginally operable, Non–small cell lung cancer, Stage IIIA, Surgery",
author = "Yang, {Kai Lin} and Chang, {Yih Chen} and Ko, {Hui Ling} and Chi, {Mau Shin} and Wang, {Hsin Ell} and Hsu, {Pei Sung} and Lin, {Chen Chun} and Yeh, {Diana Yu Wung} and Kao, {Shang Jyh} and Jiang, {Jiunn Song} and Chi, {Kwan Hwa}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.cllc.2016.05.013",
language = "English",
volume = "17",
pages = "550--557",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

AU - Yang, Kai Lin

AU - Chang, Yih Chen

AU - Ko, Hui Ling

AU - Chi, Mau Shin

AU - Wang, Hsin Ell

AU - Hsu, Pei Sung

AU - Lin, Chen Chun

AU - Yeh, Diana Yu Wung

AU - Kao, Shang Jyh

AU - Jiang, Jiunn Song

AU - Chi, Kwan Hwa

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

AB - Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

KW - Chemoradiotherapy

KW - Marginally operable

KW - Non–small cell lung cancer

KW - Stage IIIA

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84994525970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994525970&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2016.05.013

DO - 10.1016/j.cllc.2016.05.013

M3 - Article

C2 - 27378175

AN - SCOPUS:84994525970

VL - 17

SP - 550

EP - 557

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 6

ER -